{
  "created_at": "2021-01-03T01:29:11.000Z",
  "updated_at": "2021-01-06T08:25:13.847Z",
  "id": "3dbfe05c-7e71-44c5-994b-99c444c8cd3a",
  "labels": "current-affairs,2021-01-04",
  "question": "Covishield, the first vaccine to get emergency-use nod from DGCI, is being manufactured by which company?",
  "option1": "Bharat Biotech",
  "option2": "Serum Institute of India",
  "option3": "Biocon",
  "option4": "Dr Reddys Labs",
  "option5": "",
  "answer": "Serum Institute of India",
  "explanation": "Covishield is the vaccine candidate from Pune-based Serum Institute of India. It has been approved by a Subject Expert Committee (SEC) of the Drug Controller General of India (DCGI).<br />Covishield is equivalent to the vaccine being developed by the Oxford-AstraZeneca. The United Kingdom also granted emergency use approval to the vaccine in the country."
}